Prosecution Insights
Last updated: April 19, 2026
Application No. 18/603,875

SYSTEMS AND METHODS FOR ASSESSING SENSOR SURFACE AREA ENCAPSULATION IN VITRO AND IN VIVO

Non-Final OA §101§112
Filed
Mar 13, 2024
Examiner
TRAN, THO Q
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Medtronic Minimed, Inc.
OA Round
1 (Non-Final)
62%
Grant Probability
Moderate
1-2
OA Rounds
4y 3m
To Grant
99%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allow Rate
343 granted / 556 resolved
-8.3% vs TC avg
Strong +37% interview lift
Without
With
+37.4%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
38 currently pending
Career history
594
Total Applications
across all art units

Statute-Specific Performance

§101
13.3%
-26.7% vs TC avg
§103
39.2%
-0.8% vs TC avg
§102
14.7%
-25.3% vs TC avg
§112
29.9%
-10.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 556 resolved cases

Office Action

§101 §112
DETAILED ACTION Non-Final Rejection Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims Status Claims 1-20 are pending. Claim Objections Claim 1 is objected to because of the following informalities: Insert “at” before “least” in line 10. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 11 recites, “[o]ne or more non-transitory processor-readable media storing instructions which, when executed by one more processors, cause the performance of: …” The present participle form (storing) would indicates an action taking place while the claim is directed to a structure. It is unclear if the memory therefore includes the instructions as part of the structure. For purposes of examination, the Office interpreted the instructions as being included in the memory. However, the Office recommends amending the claim to state, “One or more non-transitory processor-readable media with instructions stored therein which, when executed …” or the like to overcome the rejection. The same issue applies to claims 1 and 20. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1, are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. The claim(s) recite(s) estimating, determining, and comparing functions in the body of the claim. These limitations were interpreted as mental concepts as the limitations amount to evaluations capable of being performed in the mind (i.e. there are no limitations that indicate these functions would be impossible to perform mentally). The limitations can alternatively be interpreted as mathematical concepts. Independent claims 11 and 20 rejected on the same basis as claim 1. This judicial exception is not integrated into a practical application because the final function of adjusting a calibration factor when the determined difference is below the predetermined threshold value fails to apply, rely on, or use the judicial exception in a manner that imposes a meaningful limit on the judicial exception, such that the claim is more than a drafting effort designed to monopolize the exception. More specifically, it is left unsaid what calibration factor is being adjusted (i.e. is the factor related to the system?). Also as claimed, the calibration factor adjustment only relies on the timing of a value falling below a threshold which arguably is not a meaningful limit. A practical application that uses something calculated from the previous limitations in adjusting the calibration factor of the glucose sensor would appear to be a more persuasive practical application. The other limitations of claim 1 are arguably related extra-solution data gathering or mere instructions to implement an abstract idea on a computer. The claim(s) does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception under step 2B analysis because the recitation of hardware amount to using a computer as a tool to perform an abstract idea. The acquisition of sensor data and EIS data amount to insignificant extra-solution data gathering under the step 2B analysis. Claim 2 was interpreted as additional mental concepts but could be a practical application if the claim used a different phrase than “based on.” Claim 3, 7, 9, 10, 14, 15, 16, and 19 were interpreted as additional abstract mental concepts. Claims 4-6, 17 were interpreted as additional extra-solution data gathering. Claims 8 and 18 were interpreted as limitations related to organizing human activity. Note The following reference is provided for Applicant’s benefit: Sharma et al., "Prediction of Glucose Sensor Sensitivity in the Presence of Biofouling Using Machine Learning and Electrochemical Impedance Spectroscopy," IEEE Sensors Journal, vol. 23, no. 16, pp. 18785-18797, 15 Aug.15, 2023. This article was published after the effective filing date of this application but does touch on many of the features discussed in the specification and recited in the claims. Worden et al. (US 2010/0314248) – “[0060] Cyclic voltammetric experiments were conducted by sweeping the potential of the working electrode between 200 mV and -600 mV at a scan rate of 100 mV s.sup.-1, causing fructose in the vicinity of the electrode to be reduced to mannitol in the positive direction and mannitol to be oxidized to fructose in the reverse direction. All electrochemical measurements were made in 100 mM PBS (pH 6.0) at 60.degree. C. using an electrode with a controlled surface area of 0.07 cm.sup.2. The slope of the calibration plot, which depicts peak current vs. concentration, is a measure of the biosensor's sensitivity. The maximum turnover rate (TR.sub.max), which corresponds to the number of fructose molecules reduced per TmMtDH molecule per second, was calculated using Eq. 6 (Eisenwiener and Schulz, 1969)” Li et al. (US 2015/0246814) – [0042] -“With reference to FIG. 15, as-grown CNT patterns may trap air bubbles rendering the surfaces of individual CNTs inaccessible to an electrolytic aqueous solution. As a result, it may be difficult to control the effective electrode surface area for electrochemical detection. Further, a low current response may result in difficult calibration of an associated sensor or device and difficult quantification of analyte concentration in a respective aqueous solution.” Chapman et al. (US 2023/0255527) - [0102] The sensitivity of a biosensor may be partially dependent on the active surface area of the electrodes in the biosensor. Accordingly, the calibration process can use the calculated surface area from the automated image analysis to adjust a projected sensitivity for the biosensor. Returning to the specific example above, the active surface area of the electrodes can be dependent on the number of microneedles that are formed. Accordingly, the calibration process can use the number of detected microneedles to adjust a projected sensitivity for the biosensor… [0164] In some embodiments, calibration adjustments can be generally proportional to divergence from an expected value in the performance data. For example, increases or decreases in surface area of the electrode (e.g., microneedle tips), due to variation in the electrode formation (e.g., tip geometry and/or missing microneedle tip(s)) can be used to update the calibration adjustments. Returning to the specific example above, the production data can indicate that the active area of the sensor is 80 percent of an expected value (e.g., of a mean after production). In this example, the calibration adjustments can include a signal filter that boosts the signal by 25 percent, thereby returning to about 100 percent of the expected signal strength. In another example, variation in electrode resistance and/or other electrical characteristics can be used to update the calibration adjustments (e.g., to update and/or adjust a poise potential applied to a microsensor during operation of the biosensor to account for the different electrical characteristics). Chapman provides the closest prior art as this reference teaches looking at changes in active surface area based on sensor electrical characteristics changing. However, the electrical characteristics do not include Isig, Vcntr, or EIS parameters. Choy et al. (US 2022/0031205) – see [0163] which essentially appears to include the same teachings recited above in Chapman. This reference however is associated with the assignee (Medtronic) of this application. Conclusion Claims 1-20 are rejected. Note, no prior art rejections were included in this Office Action. It is anticipated that resolution of the 112 and 101 issues will likely place the application in condition for allowance. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Tho Q. Tran whose telephone number is (571)270-1892. The examiner can normally be reached 7-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jacqueline Cheng can be reached at 5712725596. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /THO Q TRAN/Examiner, Art Unit 3791 /JACQUELINE CHENG/Supervisory Patent Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Mar 13, 2024
Application Filed
Jan 10, 2026
Non-Final Rejection — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599317
COMPACT MEDICAL DEVICE INSERTERS AND RELATED SYSTEMS AND METHODS
2y 5m to grant Granted Apr 14, 2026
Patent 12575762
Wearable Sensor and Sweating Analysis Device
2y 5m to grant Granted Mar 17, 2026
Patent 12575767
OPTICAL MEASUREMENT DEVICE AND PROBE HOLDER SET
2y 5m to grant Granted Mar 17, 2026
Patent 12575784
DEVICES AND METHODS FOR THE DETECTION OF INTRAORAL ACID EXPOSURE
2y 5m to grant Granted Mar 17, 2026
Patent 12575814
Fluid Sample Collection System
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
62%
Grant Probability
99%
With Interview (+37.4%)
4y 3m
Median Time to Grant
Low
PTA Risk
Based on 556 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month